These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 37230955

  • 1. Plasma arginine metabolites in health and chronic kidney disease.
    Au AYM, Mantik K, Bahadory F, Stathakis P, Guiney H, Erlich J, Walker R, Poulton R, Horvath AR, Endre ZH.
    Nephrol Dial Transplant; 2023 Nov 30; 38(12):2767-2775. PubMed ID: 37230955
    [Abstract] [Full Text] [Related]

  • 2. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.
    Clin Res Cardiol; 2018 Mar 30; 107(3):201-213. PubMed ID: 29101459
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
    Goonasekera CD, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ.
    J Hypertens; 1997 Aug 30; 15(8):901-9. PubMed ID: 9280214
    [Abstract] [Full Text] [Related]

  • 4. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Sapa H, Gutiérrez OM, Shlipak MG, Katz R, Ix JH, Sarnak MJ, Cushman M, Rhee EP, Kimmel PL, Vasan RS, Schrauben SJ, Feldman HI, Seegmiller JC, Brunengraber H, Hostetter TH, Schelling JR, CKD Biomarkers Consortium.
    Am J Kidney Dis; 2022 Oct 30; 80(4):502-512.e1. PubMed ID: 35351578
    [Abstract] [Full Text] [Related]

  • 5. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
    Krzystek-Korpacka M, Wiśniewski J, Fleszar MG, Bednarz-Misa I, Bronowicka-Szydełko A, Gacka M, Masłowski L, Kędzior K, Witkiewicz W, Gamian A.
    Oxid Med Cell Longev; 2019 Oct 30; 2019():5965721. PubMed ID: 31396302
    [Abstract] [Full Text] [Related]

  • 6. Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohort.
    Maas R, Mieth M, Titze SI, Hübner S, Fromm MF, Kielstein JT, Schmid M, Köttgen A, Kronenberg F, Krane V, Hausknecht B, Eckardt KU, Schneider MP.
    Nephrol Dial Transplant; 2020 Jul 01; 35(7):1187-1195. PubMed ID: 30476224
    [Abstract] [Full Text] [Related]

  • 7. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.
    Kidney Int Suppl; 2001 Feb 01; 78():S14-8. PubMed ID: 11168976
    [Abstract] [Full Text] [Related]

  • 8. Methylated arginine derivatives in children and adolescents with chronic kidney disease.
    Brooks ER, Langman CB, Wang S, Price HE, Hodges AL, Darling L, Yang AZ, Smith FA.
    Pediatr Nephrol; 2009 Jan 01; 24(1):129-34. PubMed ID: 18830716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH, von Scholten BJ, Reinhard H, Persson F, Teerlink T, Hansen TW, Parving HH, Jacobsen PK, Rossing P.
    Cardiovasc Diabetol; 2017 Jul 11; 16(1):88. PubMed ID: 28697799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
    Szlęzak D, Ufnal M, Drapała A, Samborowska E, Wróbel M.
    Amino Acids; 2023 Apr 11; 55(4):529-539. PubMed ID: 36802034
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Di Gangi IM, Chiandetti L, Gucciardi A, Moret V, Naturale M, Giordano G.
    Anal Chim Acta; 2010 Sep 16; 677(2):140-8. PubMed ID: 20837180
    [Abstract] [Full Text] [Related]

  • 19. Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.
    Jaźwińska-Kozuba A, Martens-Lobenhoffer J, Surdacki A, Kruszelnicka O, Rycaj J, Godula-Stuglik U, Bode-Böger SM.
    Int J Mol Sci; 2012 Nov 21; 13(11):15464-74. PubMed ID: 23203136
    [Abstract] [Full Text] [Related]

  • 20. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG, Aasarød KI, Sagen E, Åsberg A.
    Clin Biochem; 2015 Jul 21; 48(10-11):646-51. PubMed ID: 25828044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.